SCHEMBL4411632

SCHEMBL4411632

Oc1cccc(C2=C3C=CC(=N3)C(c3ccccc3)=C3C=CC(=N3)C(c3ccccc3)=C3C=CC(=N3)C(c3ccccc3)=C3C=CC2=N3)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B1 P14061 11/20 0.43
▸ HSD17B2 P37059 9/20 0.43
▸ CYP3A4 P08684 2/20 0.42
▸ CYP2C9 P11712 2/20 0.42
▸ ADORA1 P30542 2/20 0.37
▸ PTPN1 P18031 1/20 0.37
▸ ESR1 P03372 1/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ CYP2B6 P20813 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ ESR2 Q92731 1/20 0.37
▸ PIK3CG P48736 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ TP53 P04637 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ NFKB1 P19838 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ NFKB2 Q00653 1/20 0.36
▸ RELA Q04206 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4411533 1.00 HSD17B1 (0.43) HSD17B1HSD17B2CYP3A4CYP2C9ADORA1
SCHEMBL4412721 1.00 HSD17B1 (0.43) HSD17B1HSD17B2CYP3A4CYP2C9ADORA1
SCHEMBL249200 0.95 HSD17B1 (0.47) HSD17B1HSD17B2CYP3A4CYP2C9ESR1
SCHEMBL28049798 0.84 MMP3 (0.50) ADORA1ESR1ESR2LMNARAB9A
SCHEMBL6292615 0.84 MMP3 (0.50) ADORA1ESR1ESR2LMNARAB9A
SCHEMBL17651814 0.83 HSD17B1 (0.38) HSD17B1HSD17B2CYP3A4CYP2C9ESR1
SCHEMBL17651780 0.83 HSD17B1 (0.38) HSD17B1HSD17B2CYP3A4CYP2C9ESR1
SCHEMBL28865295 0.83 MMP3 (0.48) ADORA1ESR1ESR2LMNARAB9A
SCHEMBL28436561 0.83 MMP3 (0.48) ADORA1ESR1ESR2LMNARAB9A
SCHEMBL8179946 0.83 MMP3 (0.48) ADORA1ESR1ESR2LMNARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8071760-B2 Boron-containing porphyrin compounds and their uses BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) 2011-12-06 — — US disclosed
US-20090318680-A1 Boron-Containing Porphyrin Compounds and Their Uses BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE 2009-12-24 — — US disclosed
EP-1940416-A2 BORON-CONTAINING PORPHYRIN COMPOUNDS AND THEIR USES Board of Supervisors of Louisiana State University and Agricultural and Mechanical College (US) 2008-07-09 — — EP disclosed
WO-2007050564-A2 BORON-CONTAINING PORPHYRIN COMPOUNDS AND THEIR USES BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) 2007-05-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090318680-A1 Boron-Containing Porphyrin Compounds and Their Uses HMBS, HCCS, PPOX HSD17B1 3426/4885HSD17B2 3587/4885CYP3A4 3076/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback